Chengyuan Xing

640 citations
27 papers · 503 indexed · h-index 12
Topics
Nanoplatforms for cancer theranostics (8 papers)Nanoparticle-Based Drug Delivery (5 papers)Dendrimers and Hyperbranched Polymers (3 papers)
Partner nations
ChinaFranceJapan

In The Last Decade

Chengyuan Xing

25 papers receiving 499 citations

Peers

Chengyuan Xing
Comparison fields: 5 of 82
  • Biomaterials 132
  • Biomedical Engineering 132
  • Materials Chemistry 131
  • Inorganic Chemistry 115
  • Polymers and Plastics 112
Replace Worawan Bhanthumnavin with:
Worawan Bhanthumnavin Thailand
Marco Drache Germany
Jie Yan China
Zeinab Ansari‐Asl Iran
Yue Xu China
Xi Xu China
Liqiang Wan China
Somnath Bhattacharjee United States
Mehulkumar Patel United States
Chengyuan Xing relative to Worawan Bhanthumnavin Thailand Worawan Bhanthumnavin's profile →
Citations per field
00.5×
Worawan Bhanthumnavin · 1×
Citations per year

Countries citing papers authored by Chengyuan Xing

Since Specialization
Citations

This map shows the geographic impact of Chengyuan Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengyuan Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengyuan Xing more than expected).

Fields of papers citing papers by Chengyuan Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengyuan Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengyuan Xing. The network helps show where Chengyuan Xing may publish in the future.

Co-authorship network of co-authors of Chengyuan Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Chengyuan Xing. A scholar is included among the top collaborators of Chengyuan Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengyuan Xing. Chengyuan Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 1
4 0
5 4
6 16
7 7
8 11
9 17
10 7
11 14
12 15
13 11
14 7
15 5
16 12
17 17
18 68
19 47
20 89

About Chengyuan Xing

Chengyuan Xing is a scholar working on Biomaterials, Polymers and Plastics and Process Chemistry and Technology, having authored 27 papers that have together received 503 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (5 papers) and Dendrimers and Hyperbranched Polymers (3 papers). The work is most often cited by research in Biomaterials (132 citations), Inorganic Chemistry (115 citations) and Polymers and Plastics (112 citations). Chengyuan Xing has collaborated with scholars based in China, France and Japan. Frequent co-authors include Bang‐Jing Li, Sheng Zhang, Shilin Zeng, Li Chen, Long Xu, Yang Kang, Long Xu, Li Chen, Yupeng Guan and Jun Pang. Their work appears in journals such as Nano Letters, Journal of Hazardous Materials and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026